First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study

BACKGROUND: This phase II study evaluated the efficacy and safety of gemcitabine (G) plus paclitaxel (T) as first-line therapy in recurrent or metastatic breast cancer. METHODS: Patients with locally, recurrent or metastatic breast cancer and no prior chemotherapy for metastatic disease received G 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Allouache, Djelila, Gawande, Sulochana R, Tubiana-Hulin, Michele, Tubiana-Mathieu, Nicole, Piperno-Neumann, Sophie, Mefti, Fawzia, Bozec, Laurence, Genot, Jean-Yves
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1315334/
https://www.ncbi.nlm.nih.gov/pubmed/16316459
http://dx.doi.org/10.1186/1471-2407-5-151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1315334/
https://www.ncbi.nlm.nih.gov/pubmed/16316459
http://dx.doi.org/10.1186/1471-2407-5-151

Ejemplares similares